1. ER chaperone-metal interactions: links to protein folding disorders.
- Author
-
Tiffany-Castiglioni E and Qian Y
- Subjects
- Animals, Endoplasmic Reticulum metabolism, Endoplasmic Reticulum pathology, Endoplasmic Reticulum Chaperone BiP, Heat-Shock Proteins metabolism, Humans, Neurons metabolism, Neurons pathology, Neurotoxicity Syndromes metabolism, Neurotoxicity Syndromes pathology, Protein Folding, Proteostasis Deficiencies metabolism, Proteostasis Deficiencies pathology, Risk Assessment, Risk Factors, Endoplasmic Reticulum drug effects, Metals toxicity, Molecular Chaperones metabolism, Neurons drug effects, Neurotoxicity Syndromes etiology, Proteostasis Deficiencies chemically induced
- Abstract
Chaperones in the endoplasmic reticulum play vital roles in the folding, assembly, and post-translational modification of secretory proteins and also recycle, refold, or initiate degradation of misfolded proteins. Chaperone deficiencies in either amount or function are implicated in the etiology or pathogenesis of Alzheimer's disease and other protein folding disorders of the central nervous system. In this review, we discuss evidence that chaperones become pathologic through deleterious interactions with metals and then promote protein folding disorders. The "master regulator" chaperone GRP78 in the endoplasmic reticulum is a compelling subject for investigation in this context because it is located at the hub of signaling pathways in a complex chaperone network. It has therefore been studied by several laboratories in conjunction with exposure to toxic metals. The key points of this review are that metals are implicated in the etiology or pathogenesis of Alzheimer's disease and other protein folding disorders, metals induce the expression GRP78, often associated with oxidative stress, some metals bind to GRP78, and lead (Pb) impairs GRP78 function when it binds to GRP78. If certain metals do indeed cause or promote the aggregation of toxic proteins in the central nervous system, as the available evidence indicates, the identification of the mechanisms by which they act would provide valuable leads for the development of therapies to prevent or reverse toxic protein aggregation., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF